With a strong clinical-stage pipeline, Agenus harnesses a mix of proprietary antibody platforms, which include Retrocyte Display screen™ and SECANT®, and impressive cell therapy strategies, positioning by itself to be a critical contributor inside the biotechnology and immunotherapy arena.Protecting independence and editorial liberty is importan… Read More